Professor Clare M Lloyd

Clare Lloyd completed both her BSc and PhD degrees in Immunology at King's College London. She was awarded a Junior Research Fellowship from the National Kidney Research Fund at the United Medical and Dental Schools at Guy's Hospital to study the immune response associated with mouse models of glomerulonephritis. Thereafter she moved to the US to take up a Postdoctoral position jointly with Dr Jose-Carlos Gutierrez Ramos at Harvard University and Professor David Salant at Boston University Medical Center.

Professor Lloyd developed a mouse model of chronic inflammatory glomerulonephritis in order to study the role of infiltrating inflammatory cells in renal fibrosis. While in Dr Guteirrez-Ramos' laboratory she developed an interest in the molecular mechanisms of cell recruitment and was involved in the cloning and in vivo characterisation of several novel chemokines. She moved to Millennium Pharmaceuticals in Cambridge, USA where her role was to develop models and systems to functionally characterise novel genes of unknown function.

Professor Lloyd moved back to the UK to establish a research group at Imperial College in 1999 after being awarded a Wellcome Senior Fellow in Basic Biomedical Sciences. Her group has developed models of chronic allergic inflammation and outlined roles for cells and molecules involved in the development and regulation of pulmonary inflammation, airway hyperreactivity and airway remodelling. Her Fellowship was successfully renewed both in 2004 and 2010 and she was awarded a Personal Chair in Respiratory Immunology in 2006.

Professor Lloyd is a PI in the Medical Research Council/Asthma UK Centre in Allergic Mechanisms of Asthma and in the Wellcome Trust funded Centre for Respiratory Infection. Current projects are focussed on the mechanisms underlying the regulation and development of allergen induced airway inflammation and remodelling; development of allergic inflammation and remodelling in neonates; effects of viral exacerbations on airway inflammation and remodelling. Funding for the group comes from the Wellcome Trust, the MRC, BBSRC, BLF and Asthma UK as well as from collaboration with several Biotechnology companies in the UK and USA.

Professor Lloyd previously sat on the research committees of Asthma UK and the British Lung Foundation, and is currently  a member of the Wellcome Trust Immunology and Infectious Disease funding committee.

Finally, Clare Lloyd joins Imperial's Ambassador for Women, Maria Belvisi, in her role as Institute Lead for Women.